REPROCELL and BioBridge Global sign Memorandum of Understanding to accelerate global manufacturing services using clinical iPSCs

COVID-19 Convalescent Plasma: One-year Experience

COVID-19 Antibody Testing as a Recruitment Strategy for COVID-19 Convalescent Plasma Donors

Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month Experience

Whole blood for hemostatic resuscitation of major bleeding

Cold-stored platelets: A product with function optimized for hemorrhage control

Cold platelets for trauma-associated bleeding: regulatory approval, accreditation approval, and practice implementation-just the “tip of the iceberg”

A Review on Currently Available Potential Therapeutic Options for COVID-19

Prehospital low-titer cold-stored whole blood: Philosophy for ubiquitous utilization of O-positive product for emergency use in hemorrhage due to injury

Low Dose Radiation Therapy and Convalescent Plasma: How a Hybrid Method May Maximize Benefits for COVID-19 Patients

Immunoglobulin M anti-A and anti-B titers in South Texas group O D+ male donors

Effects of storage time prolongation on in vivo and in vitro characteristics of 4°C-stored platelets

Treatment of COVID-19 Patients with Convalescent Plasma Reveals a Signal of Significantly Decreased Mortality

Search
Close this search box.